Zintel Stephanie, Flock Charlotte, Arbogast Anna Lisa, Forster Alice, von Wagner Christian, Sieverding Monika
Department of Psychology, Ruprecht Karls University Heidelberg, Hauptstr. 47-51, 69117 Heidelberg, Germany.
Research Department of Behavioural Science and Health, University College London, 1-19 Torrington Place, London, WC1E 6BT UK.
Z Gesundh Wiss. 2022 Jan 7:1-25. doi: 10.1007/s10389-021-01677-w.
We conducted a systematic review and meta-analysis to analyse gender differences in COVID-19 vaccination intentions.
PubMed, Web of Science and PsycInfo were searched (November 2020 to January 2021) for studies reporting absolute frequencies of COVID-19 vaccination intentions by gender. Averaged odds ratios comparing vaccination intentions among men and women were computed. Descriptive analyses of the studies were reported.
Sixty studies were included in the review and data from 46 studies ( = 141,550) were available for meta-analysis. A majority (58%) of papers reported men to have higher intentions to get vaccinated against COVID-19. Meta-analytic calculations showed that significantly fewer women stated that they would get vaccinated than men, OR 1.41 (95% CI 1.28 to 1.55). This effect was evident in several countries, and the difference was bigger in samples of health care workers than in unspecified general population samples.
This systematic review and meta-analysis found lower vaccination intentions among women than men. This difference is discussed in the light of recent data on actual vaccination rates in different countries.
The online version contains supplementary material available at 10.1007/s10389-021-01677-w.
我们进行了一项系统评价和荟萃分析，以分析新冠病毒疫苗接种意愿中的性别差异。
检索了PubMed、科学网和PsycInfo（2020年11月至2021年1月），查找按性别报告新冠病毒疫苗接种意愿绝对频率的研究。计算了比较男性和女性接种意愿的平均比值比。报告了对这些研究的描述性分析。
该评价纳入了60项研究，46项研究（n = 141,550）的数据可用于荟萃分析。大多数（58%）论文报告男性接种新冠病毒疫苗的意愿更高。荟萃分析计算表明，表示会接种疫苗的女性明显少于男性，比值比为1.41（95%置信区间为1.28至1.55）。这种效应在几个国家都很明显，医护人员样本中的差异比未明确的普通人群样本中的差异更大。
这项系统评价和荟萃分析发现，女性的疫苗接种意愿低于男性。根据不同国家近期实际接种率的数据对这种差异进行了讨论。
在线版本包含可在10.1007/s10389-021-01677-w获取的补充材料。
